Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Industry:
Biotechnology, Health Care, Life Science
Technology:
diagnostics
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Investors Number:
4
Headquarters:
Taipei, T'ai-pei, Taiwan
Employee Number:
11-50
Total Funding:
$10M
Founded Date:
2015-01-01
Last Funding Type:
Series B
Last Funding Date:
2020-02-26